NEW YORK, Sept. 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BKYI, AIM, JNCE, DAL, and REKR.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • BKYI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=BKYI&prnumber=092120212
  • AIM: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AIM&prnumber=092120212
  • JNCE: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=JNCE&prnumber=092120212
  • DAL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=DAL&prnumber=092120212
  • REKR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=REKR&prnumber=092120212

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-bio-key-aim-immunotech-jounce-therapeutics-delta-air-lines-or-rekor-systems-301381493.html

SOURCE InvestorsObserver